Prev：Combating atherosclerosis with chirality/phase dual‐engineered nanozyme featuring microenvironment‐programmed senolytic and senomorphic actions.(KTB1310-27.4)
Next：Role of AMPK/ACC/SREBP-1 and MAPK Pathways in Glucose Intolerance and Liver Dysfunction of Largemouth Bass(KTB1340-)
